Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis

Tumor-derived nanovesicles have been widely used as a biomarker or therapeutic target in various tumor types. However, these nanovesicles have limited use in therapy due to the risk of advancing tumor development. Methods: Exosome-like nanovesicles (ENVs) were developed from metastatic breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Xiaolan, Li, Zhi, Han, Xuedong, Zhen, Linlin, Luo, Chao, Liu, Minmin, Yu, Kun, Ren, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525995/
https://www.ncbi.nlm.nih.gov/pubmed/31131057
http://dx.doi.org/10.7150/thno.32363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525995/
https://www.ncbi.nlm.nih.gov/pubmed/31131057
http://dx.doi.org/10.7150/thno.32363

Ejemplares similares